Telomere dysfunction and its role in haematological cancer.
about
Short telomeres: from dyskeratosis congenita to sporadic aplastic anemia and malignancyTelomerase Activation in Hematological MalignanciesTelomere length predicts progression and overall survival in chronic lymphocytic leukemia: data from the UK LRF CLL4 trial.Identification of Genes That Modulate Susceptibility to Formaldehyde and Imatinib by Functional Genomic Screening in Human Haploid KBM7 Cells.Impact of telomere length on survival in classic and variant hairy cell leukemia.Extensive telomere erosion is consistent with localised clonal expansions in Barrett's metaplasiaTelomere length varies by DNA extraction method: implications for epidemiologic research.Three-dimensional Nuclear Telomere Organization in Multiple Myeloma.Inherited genetic susceptibility to multiple myeloma.Mechanisms and Clinical Applications of Genome Instability in Multiple Myeloma.Telomere erosion in NF1 tumorigenesis.Telomere length is an independent prognostic marker in MDS but not in de novo AML.Role of the functional MNS16A VNTR-243 variant of the human telomerase reverse transcriptase gene in progression and response to therapy of patients with non-Hodgkin's B-cell lymphomas.Absolute qPCR for measuring telomere length in bone marrow samples of plasma cell disorders.Telomere length is a critical determinant for survival in multiple myeloma.In medio stat virtus: unanticipated consequences of telomere dysequilibrium.Telomeres and genomic evolution.Telomere shortening associated with increased genomic complexity in chronic lymphocytic leukemia.Telomere length in circulating lymphocytes: Association with chromosomal aberrationsThe Breakage-Fusion-Bridge Cycle ProducingMLLAmplification in a Case of Myelodysplastic Syndrome
P2860
Q26852788-C91E7DFA-CCC4-4C97-970A-7ED1D1872360Q28068238-622F39AB-AE05-4772-AF44-9D3E9223A11DQ30986040-6FFF088B-3E33-421E-B353-4AD050C59870Q35968059-AFDB0ED6-3AF8-43D9-9F6B-247B84A7220BQ36322450-D08239AA-FA82-4A11-B119-853A5397E62AQ36330022-0852DC47-1F2A-4C1C-B2AA-3E87DF29A792Q37308297-9AEB11E6-F98F-49AF-89F0-3FBE999B98CCQ37474404-51F1A8C2-E88F-464C-BF17-58858CB7AD95Q38163845-9B62370A-FEC7-4F9F-BEE6-EB7ABA51F809Q38637046-8E695F02-0908-4C12-B98C-DE07DBDCD2D6Q38814214-647C1DD3-0E1B-4C3F-9204-6F7820A85F14Q40208892-E0D1BCE7-B020-4857-85B2-99E586E6DE1DQ44058153-1F5395DF-7596-455B-B585-B0D46D8EDD9BQ46789768-90E041B2-9C18-44A0-A557-AC46AB867858Q48362611-0D767862-F7EC-486A-BC53-81C82495A19EQ52394558-2BC6D9C3-D189-4D3E-A31D-11DBB8B286C7Q52687715-6F3AE686-A7F6-4D35-BF9D-6A0F852CEF2FQ52941092-0DB0F7C3-7F73-496C-814B-18E5ECAD3777Q57664743-747634A1-F68B-4D22-8000-E8989E45DCA1Q58919721-5C162521-C667-4326-BF42-7B560AFAF466
P2860
Telomere dysfunction and its role in haematological cancer.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Telomere dysfunction and its role in haematological cancer.
@en
Telomere dysfunction and its role in haematological cancer.
@nl
type
label
Telomere dysfunction and its role in haematological cancer.
@en
Telomere dysfunction and its role in haematological cancer.
@nl
prefLabel
Telomere dysfunction and its role in haematological cancer.
@en
Telomere dysfunction and its role in haematological cancer.
@nl
P2860
P1476
Telomere dysfunction and its role in haematological cancer
@en
P2093
Ceri H Jones
Chris Pepper
P2860
P304
P356
10.1111/J.1365-2141.2011.09022.X
P407
P50
P577
2012-01-11T00:00:00Z